Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#638 most reported symptom for this vaccine
Upper respiratory tract infection has been reported 11 times in association with HPV (Gardasil 9) vaccination in VAERS. This represents 0.0% of all 26,909 reports for this vaccine.
Among these reports, 2 mentioned death (18.18%) and 2 involved hospitalization (18.2%).
Upper respiratory tract infection is the #638 most frequently reported symptom for HPV (Gardasil 9) out of 1593 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 11 reports of Upper respiratory tract infection after HPV (Gardasil 9) vaccination may seem alarming, but context is critical.
The 18.18% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.